M

Metcela Inc.

9 employees

Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
heart failure
biotechnology
Health Care
cell therapy
Medical

Date founded

2016

Funding rounds raised

Total raised

$14M

from 15 investors over 15 rounds

M

Metcela Inc. raised $14M on June 28, 2022

Investors: Japan Lifeline Co., Ltd., Sony Innovation Fund, Reazon Holdings, inc. and Cyberdyne

M

Metcela Inc. raised $13M on January 4, 2021

Investors: Sony Innovation Fund, Japan Lifeline Co., Ltd., F-Prime Capital Partners and The Dai-ichi Life Insurance Company, Limited

M

Metcela Inc. raised $4M on March 18, 2020

Investors: Sony Innovation Fund and Japan Lifeline Co., Ltd.

M

Metcela Inc. raised undisclosed on September 18, 2018

Investors: New Energy and Industrial Technology Development Organization (NEDO)

M

Metcela Inc. raised $4.7M on August 30, 2018

Investors: Japan Lifeline Co., Ltd., F-Prime Capital Partners, New Energy and Industrial Technology Development Organization (NEDO) and The Dai-ichi Life Insurance Company, Limited

FAQ